Dark

ALNY20250417P280
ALNY Apr 17 2025 280.00 Put (ALNY250417P00280000)
option OPRA

Expired

Apr 10, 2025

49.70+33.818%(+12.56)1

Overview Historical

open chart

1 day

Skyline

O49.70 H49.70 L49.70 C49.70 V1 OI59

MA 50 close 0.00

MA 200 close 0.00

Headquarters

Cambridge, Massachusetts, USA

Industry

Biotechnology

Sector

Healthcare

Profile

alnylam is developing an entirely new class of innovative medicines based on a breakthrough discovery in biology known as rna interference, or rnai. with rnai technology, we have the opportunity to treat disease and impact the lives of patients in a fundamentally new way by silencing disease-causing genes upstream of today's medicines.